• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

博尔纳正嗜神经病毒1型X蛋白在肌萎缩侧索硬化症中的神经保护作用

The Neuroprotective Effect of the X Protein of Orthobornavirus Bornaense Type 1 in Amyotrophic Lateral Sclerosis.

作者信息

Tournezy Jeflie, Léger Claire, Klonjkowski Bernard, Gonzalez-Dunia Daniel, Szelechowski Marion, Garenne André, Mathis Stéphane, Chevallier Stéphanie, Le Masson Gwendal

机构信息

Neurocentre Magendie INSERM U1215, Université de Bordeaux, 33000 Bordeaux, France.

UMR 1161 Virologie, INRA, ANSES, Ecole Nationale Vétérinaire d'Alfort, 94700 Maisons-Alfort, France.

出版信息

Int J Mol Sci. 2024 Nov 28;25(23):12789. doi: 10.3390/ijms252312789.

DOI:10.3390/ijms252312789
PMID:39684507
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11641280/
Abstract

In amyotrophic lateral sclerosis (ALS), early mitochondrial dysfunction may contribute to progressive motor neuron loss. Remarkably, the ectopic expression of the Orthobornavirus bornaense type 1 (BoDV-1) X protein in mitochondria blocks apoptosis and protects neurons from degeneration. Therefore, this study examines the neuroprotective effects of X protein in an ALS mouse model. We first tested in vitro the effect of the X-derived peptide (PX3) on motoneurons primary cultures of SOD1 mice. The total intracellular adenosine triphosphate (ATP) content was measured after incubation of the peptide. We next tested in vivo the intramuscular injection of X protein using a canine viral vector (CAV2-X) and PX3 intranasal administrations in mice. Disease onset and progression were assessed through rotarod performance, functional motor unit analysis via electrophysiology, and motor neuron survival by immunohistochemistry. The results showed that in vitro PX3 restored the ATP level in SOD1 motor neurons. In vivo, treated mice demonstrated better motor performance, preserved motor units, and higher motor neuron survival. Although life expectancy was not extended in this severe mouse model of motor neuron degeneration, the present findings clearly demonstrate the neuroprotective potential of X protein in a model of ALS. We are convinced that further studies may improve the therapeutic impact of X protein with optimized administration methods.

摘要

在肌萎缩侧索硬化症(ALS)中,早期线粒体功能障碍可能导致运动神经元进行性丧失。值得注意的是,博尔纳病毒1型(BoDV-1)X蛋白在线粒体中的异位表达可阻止细胞凋亡并保护神经元免于退化。因此,本研究考察了X蛋白在ALS小鼠模型中的神经保护作用。我们首先在体外测试了X衍生肽(PX3)对SOD1小鼠运动神经元原代培养物的影响。在肽孵育后测量细胞内三磷酸腺苷(ATP)的总含量。接下来,我们在体内测试了使用犬病毒载体(CAV2-X)肌肉注射X蛋白和对小鼠鼻内施用PX3的效果。通过转棒试验评估疾病的发作和进展,通过电生理学进行功能性运动单位分析,并通过免疫组织化学评估运动神经元的存活情况。结果表明,在体外,PX3恢复了SOD1运动神经元中的ATP水平。在体内,接受治疗的小鼠表现出更好的运动性能、保留的运动单位和更高的运动神经元存活率。尽管在这个严重的运动神经元退化小鼠模型中预期寿命没有延长,但目前的研究结果清楚地证明了X蛋白在ALS模型中的神经保护潜力。我们相信,进一步的研究可能会通过优化给药方法来提高X蛋白的治疗效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e0b/11641280/342a262e9f04/ijms-25-12789-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e0b/11641280/64008ec7010b/ijms-25-12789-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e0b/11641280/98bc10960067/ijms-25-12789-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e0b/11641280/5dc74b374912/ijms-25-12789-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e0b/11641280/b212fe3f95e5/ijms-25-12789-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e0b/11641280/1b7abc8b6e22/ijms-25-12789-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e0b/11641280/eee9f0797619/ijms-25-12789-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e0b/11641280/342a262e9f04/ijms-25-12789-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e0b/11641280/64008ec7010b/ijms-25-12789-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e0b/11641280/98bc10960067/ijms-25-12789-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e0b/11641280/5dc74b374912/ijms-25-12789-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e0b/11641280/b212fe3f95e5/ijms-25-12789-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e0b/11641280/1b7abc8b6e22/ijms-25-12789-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e0b/11641280/eee9f0797619/ijms-25-12789-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e0b/11641280/342a262e9f04/ijms-25-12789-g007.jpg

相似文献

1
The Neuroprotective Effect of the X Protein of Orthobornavirus Bornaense Type 1 in Amyotrophic Lateral Sclerosis.博尔纳正嗜神经病毒1型X蛋白在肌萎缩侧索硬化症中的神经保护作用
Int J Mol Sci. 2024 Nov 28;25(23):12789. doi: 10.3390/ijms252312789.
2
AAV-NRIP gene therapy ameliorates motor neuron degeneration and muscle atrophy in ALS model mice.腺相关病毒-核受体相互作用蛋白基因疗法改善了肌萎缩侧索硬化症模型小鼠的运动神经元变性和肌肉萎缩。
Skelet Muscle. 2024 Jul 24;14(1):17. doi: 10.1186/s13395-024-00349-z.
3
Cdk5 inhibition in the SOD1 transgenic mouse model of amyotrophic lateral sclerosis suppresses neurodegeneration and extends survival.Cdk5 抑制在肌萎缩侧索硬化症的 SOD1 转基因小鼠模型中抑制神经退行性变并延长生存期。
J Neurochem. 2024 Sep;168(9):2908-2925. doi: 10.1111/jnc.16160. Epub 2024 Jun 27.
4
Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.胍那苄可延缓疾病症状的出现,延长寿命,改善运动能力,并减轻肌萎缩侧索硬化症SOD1 G93A小鼠模型中的运动神经元损失。
Neuroscience. 2014 Sep 26;277:132-8. doi: 10.1016/j.neuroscience.2014.03.047. Epub 2014 Mar 31.
5
PACAP signaling exerts opposing effects on neuroprotection and neuroinflammation during disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.PACAP 信号在 SOD1(G93A)肌萎缩侧索硬化症小鼠模型疾病进展过程中对神经保护和神经炎症产生相反的影响。
Neurobiol Dis. 2013 Jun;54:32-42. doi: 10.1016/j.nbd.2013.02.010. Epub 2013 Mar 4.
6
Neuroprotective effects of JGK-263 in transgenic SOD1-G93A mice of amyotrophic lateral sclerosis.JGK-263对肌萎缩侧索硬化转基因SOD1-G93A小鼠的神经保护作用。
J Neurol Sci. 2014 May 15;340(1-2):112-6. doi: 10.1016/j.jns.2014.03.008. Epub 2014 Mar 12.
7
The Overexpression of TDP-43 Protein in the Neuron and Oligodendrocyte Cells Causes the Progressive Motor Neuron Degeneration in the SOD1 G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis.在超氧化物歧化酶1(SOD1)G93A转基因肌萎缩侧索硬化小鼠模型中,神经元和少突胶质细胞中TDP - 43蛋白的过表达导致进行性运动神经元变性。
Int J Biol Sci. 2016 Aug 15;12(9):1140-9. doi: 10.7150/ijbs.15938. eCollection 2016.
8
Transcriptomic indices of fast and slow disease progression in two mouse models of amyotrophic lateral sclerosis.两种肌萎缩侧索硬化症小鼠模型中快速和缓慢疾病进展的转录组学指标。
Brain. 2013 Nov;136(Pt 11):3305-32. doi: 10.1093/brain/awt250. Epub 2013 Sep 24.
9
In-vivo genetic ablation of metabotropic glutamate receptor type 5 slows down disease progression in the SOD1 mouse model of amyotrophic lateral sclerosis.体内遗传敲除代谢型谷氨酸受体 5 可减缓肌萎缩侧索硬化症 SOD1 小鼠模型的疾病进展。
Neurobiol Dis. 2019 Sep;129:79-92. doi: 10.1016/j.nbd.2019.05.007. Epub 2019 May 15.
10
ALS-associated mutation SOD1 leads to abnormal mitochondrial dynamics in osteocytes.肌萎缩侧索硬化症相关突变 SOD1 导致成骨细胞中线粒体动力学异常。
Bone. 2018 Jan;106:126-138. doi: 10.1016/j.bone.2017.10.010. Epub 2017 Oct 10.

引用本文的文献

1
Ex vivo study of neuroinvasive and neurotropic viruses: what is current and what is next.神经侵袭性和嗜神经病毒的体外研究:现状与未来
FEMS Microbiol Rev. 2025 Jan 14;49. doi: 10.1093/femsre/fuaf024.
2
Global burden of motor neuron disease: unraveling socioeconomic disparities, aging dynamics, and divergent future trajectories (1990-2040).运动神经元病的全球负担:揭示社会经济差异、老龄化动态及不同的未来轨迹(1990 - 2040年)
J Neurol. 2025 May 11;272(6):390. doi: 10.1007/s00415-025-13130-z.

本文引用的文献

1
Non-cell-autonomous pathogenic mechanisms in amyotrophic lateral sclerosis.非细胞自主的肌萎缩侧索硬化症发病机制。
Trends Neurosci. 2021 Aug;44(8):658-668. doi: 10.1016/j.tins.2021.04.008. Epub 2021 May 15.
2
Mitochondrial dysfunction and traffic jams in amyotrophic lateral sclerosis.线粒体功能障碍与肌萎缩侧索硬化症中的交通堵塞。
Mitochondrion. 2021 May;58:102-110. doi: 10.1016/j.mito.2021.02.008. Epub 2021 Feb 25.
3
ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now?肌萎缩侧索硬化症的遗传学、发病机制与治疗:我们目前所处的位置?
Front Neurosci. 2019 Dec 6;13:1310. doi: 10.3389/fnins.2019.01310. eCollection 2019.
4
Amyotrophic lateral sclerosis - a multisystem neurodegenerative disorder.肌萎缩侧索硬化症——一种多系统神经退行性疾病。
Nat Rev Neurol. 2019 Jan;15(1):5-6. doi: 10.1038/s41582-018-0103-y.
5
Metabolic Reprogramming in Amyotrophic Lateral Sclerosis.肌萎缩侧索硬化症中的代谢重编程。
Sci Rep. 2018 Mar 2;8(1):3953. doi: 10.1038/s41598-018-22318-5.
6
Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications.与肌萎缩侧索硬化相关的新基因:诊断及临床意义
Lancet Neurol. 2018 Jan;17(1):94-102. doi: 10.1016/S1474-4422(17)30401-5. Epub 2017 Nov 16.
7
Amyotrophic Lateral Sclerosis.肌萎缩侧索硬化症
N Engl J Med. 2017 Jul 13;377(2):162-172. doi: 10.1056/NEJMra1603471.
8
The role of mitochondria in amyotrophic lateral sclerosis.线粒体在肌萎缩侧索硬化症中的作用。
Neurosci Lett. 2019 Sep 25;710:132933. doi: 10.1016/j.neulet.2017.06.052. Epub 2017 Jun 30.
9
Management and therapeutic perspectives in amyotrophic lateral sclerosis.肌萎缩侧索硬化症的管理与治疗前景
Expert Rev Neurother. 2017 Mar;17(3):263-276. doi: 10.1080/14737175.2016.1227705. Epub 2016 Sep 20.
10
Activation of HIPK2 Promotes ER Stress-Mediated Neurodegeneration in Amyotrophic Lateral Sclerosis.HIPK2的激活促进肌萎缩侧索硬化症中内质网应激介导的神经退行性变。
Neuron. 2016 Jul 6;91(1):41-55. doi: 10.1016/j.neuron.2016.05.021. Epub 2016 Jun 16.